192 related articles for article (PubMed ID: 10506306)
21. Economic appraisal of citalopram in the management of single-episode depression.
Sclar DA; Skaer TL; Robison LM; Galin RS
J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):47S-54S. PubMed ID: 10507508
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of cost savings to a state Medicaid program following a sertraline tablet-splitting program.
Vuchetich PJ; Garis RI; Jorgensen AM
J Am Pharm Assoc (2003); 2003; 43(4):497-502. PubMed ID: 12952314
[TBL] [Abstract][Full Text] [Related]
23. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
Preskorn S
Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():13-9. PubMed ID: 7963446
[TBL] [Abstract][Full Text] [Related]
24. Are paroxetine, fluoxetine, and sertraline equally effective for depression?
Straton JB; Cronholm P
J Fam Pract; 2002 Mar; 51(3):285. PubMed ID: 11978244
[No Abstract] [Full Text] [Related]
25. Antidepressant pharmacotherapy: economic evaluation of fluoxetine, paroxetine and sertraline in a health maintenance organization.
Sclar DA; Robison LM; Skaer TL; Galin RS; Legg RF; Nemec NL; Hughes TE; Buesching DP; Morgan M
J Int Med Res; 1995; 23(6):395-412. PubMed ID: 8746607
[TBL] [Abstract][Full Text] [Related]
26. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
[TBL] [Abstract][Full Text] [Related]
27. Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid program.
Hamer AM; Hartung DM; Haxby DG; Ketchum KL; Pollack DA
J Manag Care Pharm; 2006; 12(6):449-56. PubMed ID: 16925452
[TBL] [Abstract][Full Text] [Related]
28. Relevance of serum nitric oxide levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation: decreased nitric oxide is associated with premature ejaculation.
Otunctemur A; Ozbek E; Kirecci SL; Ozcan L; Dursun M; Cekmen M; Ozdogan HK
Andrologia; 2014; 46(9):951-5. PubMed ID: 24118023
[TBL] [Abstract][Full Text] [Related]
29. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
Meyer JH; Wilson AA; Sagrati S; Hussey D; Carella A; Potter WZ; Ginovart N; Spencer EP; Cheok A; Houle S
Am J Psychiatry; 2004 May; 161(5):826-35. PubMed ID: 15121647
[TBL] [Abstract][Full Text] [Related]
30. Economic consequences of selective serotonin reuptake inhibitor use with drugs also metabolized by the cytochrome P-450 system.
Ozminkowski RJ; Hylan TR; Melfi CA; Meneades LM; Crown WH; Croghan TW; Robinson RL
Clin Ther; 1998; 20(4):780-96. PubMed ID: 9737837
[TBL] [Abstract][Full Text] [Related]
31. Using secondary binding properties to select a not so selective serotonin reuptake inhibitor.
Stahl SM
J Clin Psychiatry; 1998 Dec; 59(12):642-3. PubMed ID: 9921697
[No Abstract] [Full Text] [Related]
32. Response to Editorial Comments to Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation.
Kirecci SL; Simsek A; Gurbuz ZG; Mimaroglu S; Yuksel A; Vural P; Degirmencioglu S
Int J Urol; 2014 Sep; 21(9):921-2. PubMed ID: 24824946
[No Abstract] [Full Text] [Related]
33. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME
J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
[TBL] [Abstract][Full Text] [Related]
34. Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.
Fava M; Judge R; Hoog SL; Nilsson ME; Koke SC
J Clin Psychiatry; 2000 Nov; 61(11):863-7. PubMed ID: 11105740
[TBL] [Abstract][Full Text] [Related]
35. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
36. Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation.
Kirecci SL; Simsek A; Gurbuz ZG; Mimaroglu S; Yuksel A; Vural P; Degirmencioglu S
Int J Urol; 2014 Sep; 21(9):917-20. PubMed ID: 24712716
[TBL] [Abstract][Full Text] [Related]
37. Which of available selective serotonin reuptake inhibitors (SSRIs) is more effective in treatment of premature ejaculation? A randomized clinical trial.
Siroosbakht S; Rezakhaniha S; Rezakhaniha B
Int Braz J Urol; 2019; 45(6):1209-1215. PubMed ID: 31808410
[TBL] [Abstract][Full Text] [Related]
38. A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions.
Sullivan PW; Valuck R; Saseen J; MacFall HM
CNS Drugs; 2004; 18(13):911-32. PubMed ID: 15521793
[TBL] [Abstract][Full Text] [Related]
39. Editorial Comment from Dr Amano to Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation.
Amano T
Int J Urol; 2014 Sep; 21(9):921. PubMed ID: 24796603
[No Abstract] [Full Text] [Related]
40. Editorial Comment from Dr Sato to Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation.
Sato Y
Int J Urol; 2014 Sep; 21(9):920. PubMed ID: 24796377
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
